anonymous
Guest
anonymous
Guest
JPM 2022: Amid underwhelming Aduhelm launch, Biogen supports limited Medicare coverage, exec says | FiercePharma
JPM 2022: Amid underwhelming Aduhelm launch, Biogen supports limited Medicare coverage, exec says
JPM 2022: Amid underwhelming Aduhelm launch, Biogen supports limited Medicare coverage, exec says